Related Experiment Videos
[Chronic recurrent multifocal osteomyelitis: report of five cases]
S Guillén Martín1, S Belda Hofheinz, P Rojo Conejo
1Unidad de Niños Pequeños e Inmunodeficiencias, Departamento de Pediatría, Hospital 12 de Octubre, Madrid, España. saraguillen@wanadoo.es
Anales De Pediatria (Barcelona, Spain : 2003)
|June 2, 2005
Summary
Chronic recurrent multifocal osteomyelitis (CRMO) is a rare pediatric bone disease. New treatments like azithromycin and calcitonin show promise for children unresponsive to NSAIDs.
Area of Science:
- Pediatric Rheumatology
- Pediatric Infectious Diseases
- Pediatric Orthopedics
Background:
- Chronic recurrent multifocal osteomyelitis (CRMO) is a rare, painful inflammatory bone condition primarily affecting children.
- Its etiology remains largely unknown, presenting diagnostic and therapeutic challenges.
Observation:
- This study reviews five pediatric CRMO cases managed at a tertiary infectious diseases clinic.
- Data collected included epidemiological, clinical, radiological, laboratory, microbiological, and histological findings.
Findings:
- CRMO management lacks a specific treatment protocol.
- A combination of azithromycin and calcitonin emerged as a potential therapeutic option for children with persistent symptoms despite non-steroidal anti-inflammatory drug (NSAID) treatment.
Implications:
- This case series highlights the need for further research into CRMO pathogenesis and treatment optimization.
- Exploring novel therapeutic strategies like azithromycin-calcitonin combinations may improve outcomes for affected children.